Gradenigo's syndrome
Gradenigo's syndrome is a rare medical condition characterized by a triad of symptoms: suppurative otitis media, severe pain in the distribution of the first and second divisions of the trigeminal nerve, and abducens nerve palsy. It is named after the Italian otologist, Giuseppe Gradenigo, who first described the syndrome in 1907.
Symptoms[edit | edit source]
The primary symptoms of Gradenigo's syndrome include:
- Otitis media: This is an infection or inflammation of the middle ear. This condition can cause severe pain and may be associated with a fever.
- Trigeminal neuralgia: This is characterized by severe facial pain in the distribution of the trigeminal nerve. The pain is often described as a sharp, shooting, or electric shock-like sensation.
- Abducens nerve palsy: This condition causes weakness or paralysis of the muscles that move the eye. It can result in double vision and other visual disturbances.
Causes[edit | edit source]
Gradenigo's syndrome is typically caused by the spread of an infection from the middle ear to the nearby bones and nerves. This can occur as a complication of chronic otitis media, especially if the infection is not adequately treated.
Diagnosis[edit | edit source]
The diagnosis of Gradenigo's syndrome is based on the characteristic triad of symptoms. Additional tests, such as a CT scan or MRI, may be used to confirm the diagnosis and assess the extent of the infection.
Treatment[edit | edit source]
The treatment of Gradenigo's syndrome typically involves antibiotics to treat the underlying infection. In some cases, surgery may be necessary to drain the infection and prevent further spread.
Prognosis[edit | edit source]
With prompt and appropriate treatment, the prognosis for Gradenigo's syndrome is generally good. However, if left untreated, the condition can lead to serious complications, including meningitis, brain abscess, and sepsis.
See also[edit | edit source]
Gradenigo's syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD